{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:43:16Z","timestamp":1780418596605,"version":"3.54.1"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Chronic liver disease is one of the biggest threats to public health worldwide. Worryingly, the incidence of liver disease is dramatically rising due to the aging of the population and the global epidemics of obesity. Both are major risk factors for chronic liver disease and adverse prognostic factors, causing an increase in mortality rate. It is of great concern that 80\u201395% of obese people have non-alcoholic fatty liver disease, the major precursor for liver failure and a global health challenge. Currently, the only curative treatment for advanced chronic liver disease is liver transplantation, which is, however, hampered by high treatment costs and the scarcity of donor organs. New strategies are therefore urgently needed to prevent and reverse chronic liver disease. And for that it is essential to understand better the molecular mechanisms underlying human disease. This review focuses on the abnormalities in the regulation of translation by RNA-binding proteins during chronic liver disease and their pathological impact on portal hypertension, fibrosis, steatosis, neovascularization, and cancer development.<\/jats:p>","DOI":"10.3389\/fphys.2021.795298","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T13:50:24Z","timestamp":1638366624000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Translational Control in Liver Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Alexandra","family":"Balvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1464-5491.2005.01748.x","article-title":"Recent concepts in non-alcoholic fatty liver disease.","volume":"22","author":"Adams","year":"2005","journal-title":"Diabet. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1002457","DOI":"10.1371\/journal.pgen.1002457","article-title":"Cytoplasmic polyadenylation element binding protein deficiency stimulates PTEN and Stat3 mRNA translation and induces hepatic insulin resistance.","volume":"8","author":"Alexandrov","year":"2012","journal-title":"PLoS Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/nature06809","article-title":"A deadenylation negative feedback mechanism governs meiotic metaphase arrest.","volume":"452","author":"Belloc","year":"2008","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jns.2016.02.032","article-title":"Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.","volume":"363","author":"Boustani","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1101\/gad.1697808","article-title":"CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation.","volume":"22","author":"Burns","year":"2008","journal-title":"Genes Dev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"982.e30","DOI":"10.1053\/j.gastro.2015.11.038","article-title":"Sequential functions of CPEB1 and CPEB4 regulate pathologic expression of vascular endothelial growth factor and angiogenesis in chronic liver disease.","volume":"150","author":"Calderone","year":"2016","journal-title":"Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of liver diseases.","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e107961","DOI":"10.1371\/journal.pone.0107961","article-title":"Arsenite-activated JNK signaling enhances CPEB4-vinexin interaction to facilitate stress granule assembly and cell survival.","volume":"9","author":"Chang","year":"2014","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/emboj.2011.448","article-title":"CPEB2-eEF2 interaction impedes HIF-1\u03b1 RNA translation: translation control at elongation.","volume":"31","author":"Chen","year":"2012","journal-title":"EMBO J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5673","DOI":"10.21873\/anticanres.11150","article-title":"Regulation of the expression of cytoplasmic polyadenylation element binding proteins for the treatment of cancer.","volume":"36","author":"Chen","year":"2016","journal-title":"Anticancer Res."},{"key":"B12","doi-asserted-by":"crossref","first-page":"108322","DOI":"10.1016\/j.abb.2020.108322","article-title":"CPEB1 or CPEB4 knockdown suppresses the TAK1 and Smad signalings in THP-1 macrophage-like cells and dermal fibroblasts.","volume":"683","author":"Cui","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"B13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.4161\/nucl.36360","article-title":"Implications of polyadenylation in health and disease.","volume":"5","author":"Curinha","year":"2014","journal-title":"Nucleus"},{"key":"B14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrc3485","article-title":"Translational control of cell growth and malignancy by the CPEBs.","volume":"13","author":"D\u2019Ambrogio","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"a032649","DOI":"10.1101\/cshperspect.a032649","article-title":"Translation elongation and recoding in eukaryotes.","volume":"10","author":"Dever","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.celrep.2015.04.061","article-title":"SUMOylation is an inhibitory constraint that regulates the prion-like aggregation and activity of CPEB3.","volume":"11","author":"Drisaldi","year":"2015","journal-title":"Cell Rep."},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-48382-5_14","article-title":"Adipocyte-macrophage cross-talk in obesity","author":"Engin","year":"2017","journal-title":"Obesity and Lipotoxicity [Internet]"},{"key":"B18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement.","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/hep.27343","article-title":"Molecular pathophysiology of portal hypertension: FERNANDEZ.","volume":"61","author":"Fernandez","year":"2015","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11901-016-0306-x","article-title":"Pathogenesis of portal hypertension: extrahepatic mechanisms.","volume":"15","author":"Fernandez","year":"2016","journal-title":"Curr. Hepatol. Rep."},{"key":"B21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.arr.2012.03.004","article-title":"The CPEB-family of proteins, translational control in senescence and cancer.","volume":"11","author":"Fern\u00e1ndez-Miranda","year":"2012","journal-title":"Ageing Res. Rev."},{"key":"B22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrendo.2009.62","article-title":"The role of interleukins in insulin resistance and type 2 diabetes mellitus.","volume":"5","author":"F\u00e8ve","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.neuron.2015.05.021","article-title":"The persistence of hippocampal-based memory requires protein synthesis mediated by the prion-like protein CPEB3.","volume":"86","author":"Fioriti","year":"2015","journal-title":"Neuron"},{"key":"B24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","article-title":"Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.","volume":"131","author":"Fischer","year":"2007","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1136\/gutjnl-2015-311157","article-title":"Role and therapeutic potential of vascular stem\/progenitor cells in pathological neovascularisation during chronic portal hypertension.","volume":"66","author":"Garcia-Pras","year":"2017","journal-title":"Gut"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0138794","DOI":"10.1371\/journal.pone.0138794","article-title":"Global analysis of CPEBs reveals sequential and non-redundant functions in mitotic cell cycle.","volume":"10","author":"Giangarr\u00e0","year":"2015","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","article-title":"Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma.","volume":"30","author":"Gomes","year":"2016","journal-title":"Cancer Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1042\/BJ20081353","article-title":"Cytoplasmic polyadenylation-element-binding protein (CPEB)1 and 2 bind to the HIF-1a mRNA 3\u2019-UTR and modulate HIF-1a protein expression.","volume":"417","author":"H\u00e4gele","year":"2009","journal-title":"Biochem. J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/0092-8674(94)90547-9","article-title":"CPEB is a specificity factor that mediates cytoplasmic polyadenylation during Xenopirs oocyte maturation.","volume":"79","author":"Hake","year":"1994","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00018-007-7447-6","article-title":"Post-transcriptional gene regulation: from genome-wide studies to principles.","volume":"65","author":"Halbeisen","year":"2008","journal-title":"Cell Mol. Life Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.2147\/OTT.S87587","article-title":"Expression of CPEB4 in invasive ductal breast carcinoma and its prognostic significance.","volume":"2015","author":"Han","year":"2015","journal-title":"Onco Targets Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"a032656","DOI":"10.1101\/cshperspect.a032656","article-title":"Translation termination and ribosome recycling in eukaryotes.","volume":"10","author":"Hellen","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e979","DOI":"10.1097\/md.0000000000000979","article-title":"Expression of CPEB4 in human glioma and its correlations with prognosis.","volume":"94","author":"Hu","year":"2015","journal-title":"Medicine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.devcel.2014.07.008","article-title":"Cpeb4-mediated translational regulatory circuitry controls terminal erythroid differentiation.","volume":"30","author":"Hu","year":"2014","journal-title":"Dev. Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1136\/gutjnl-2017-315691","article-title":"Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation.","volume":"67","author":"Ibrahim","year":"2018","journal-title":"Gut"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1038\/emboj.2010.111","article-title":"Meiosis requires a translational positive loop where CPEB1 ensues its replacement by CPEB4.","volume":"29","author":"Igea","year":"2010","journal-title":"EMBO J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1128\/MCB.00800-14","article-title":"CPEB regulation of TAK1 synthesis mediates cytokine production and the inflammatory immune response.","volume":"35","author":"Ivshina","year":"2015","journal-title":"Mol. Cell Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-cellbio-101011-155831","article-title":"Cytoplasmic polyadenylation element binding proteins in development, health, and disease.","volume":"30","author":"Ivshina","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1210\/jc.2013-3092","article-title":"Toll-like receptor status in obesity and metabolic syndrome: a translational perspective.","volume":"99","author":"Jialal","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1128\/mcb.00716-10","article-title":"CPEB4 is a cell survival protein retained in the nucleus upon ischemia or endoplasmic reticulum calcium depletion.","volume":"30","author":"Kan","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1101\/gad.1593007","article-title":"RINGO\/cdk1 and CPEB mediate poly(A) tail stabilization and translational regulation by ePAB.","volume":"21","author":"Kim","year":"2007","journal-title":"Genes Dev."},{"key":"B42","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1101\/gad.208306.112","article-title":"Circadian control of mRNA polyadenylation dynamics regulates rhythmic protein expression.","volume":"26","author":"Kojima","year":"2012","journal-title":"Genes Dev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jhep.2020.10.030","article-title":"Hepatokines and adipokines in NASH-related hepatocellular carcinoma.","volume":"74","author":"Kucukoglu","year":"2021","journal-title":"J. Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3389\/fimmu.2017.00801","article-title":"Placental growth factor contributes to liver inflammation, angiogenesis, fibrosis in mice by promoting hepatic macrophage recruitment and activation.","volume":"8","author":"Li","year":"2017","journal-title":"Front. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1517\/14728220903431069","article-title":"The NF-\u03baB activation pathways, emerging molecular targets for cancer prevention and therapy.","volume":"14","author":"Lin","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"B46","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the dependency of cellular protein levels on mRNA abundance.","volume":"165","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease.","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/ncb3461","article-title":"Circadian- and UPR-dependent control of CPEB4 mediates a translational response to counteract hepatic steatosis under ER stress.","volume":"19","author":"Maillo","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1039\/c5mb00310e","article-title":"Next-generation analysis of gene expression regulation \u2013 comparing the roles of synthesis and degradation.","volume":"11","author":"McManus","year":"2015","journal-title":"Mol. BioSyst."},{"key":"B50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s43152-020-00013-w","article-title":"Crosstalk between angiogenesis and fibrogenesis in liver disease.","volume":"1","author":"Mejias","year":"","journal-title":"Curr. Tissue Microenviron. Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/j.gastro.2020.03.008","article-title":"CPEB4 increases expression of PFKFB3 to induce glycolysis and activate mouse and human hepatic stellate cells, promoting liver fibrosis.","volume":"159","author":"Mejias","year":"","journal-title":"Gastroenterology"},{"key":"B52","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S1097-2765(00)00121-0","article-title":"Phosphorylation of CPEB by Eg2 mediates the recruitment of CPSF into an active cytoplasmic polyadenylation complex.","volume":"6","author":"Mendez","year":"2000","journal-title":"Mol. Cell"},{"key":"B53","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1126\/science.1111443","article-title":"From birth to death: the complex lives of eukaryotic mRNAs.","volume":"309","author":"Moore","year":"2005","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","first-page":"7698","DOI":"10.1093\/nar\/gkq635","article-title":"CPEB2, CPEB3 and CPEB4 are coordinately regulated by miRNAs recognizing conserved binding sites in paralog positions of their 3\u2032-UTRs.","volume":"38","author":"Morgan","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1038\/onc.2015.350","article-title":"CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis.","volume":"35","author":"Nagaoka","year":"2016","journal-title":"Oncogene"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.1038\/onc.2011.650","article-title":"Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression.","volume":"31","author":"Nairism\u00e4gi","year":"2012","journal-title":"Oncogene"},{"key":"B57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11154-016-9339-2","article-title":"The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH).","volume":"17","author":"Nati","year":"2016","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"B58","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites.","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/ncb2046","article-title":"Mitotic cell-cycle progression is regulated by CPEB1 and CPEB4-dependent translational control.","volume":"12","author":"Novoa","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nm.2540","article-title":"Key contribution of CPEB4-mediated translational control to cancer progression.","volume":"18","author":"Ortiz-Zapater","year":"2012","journal-title":"Nat. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1101\/gad.5.9.1697","article-title":"Maturation-specific polyadenylation: in vitro activation by p34cdc2 and phosphorylation of a 58-kD CPE-binding protein.","volume":"5","author":"Paris","year":"1991","journal-title":"Genes Dev."},{"key":"B62","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nsmb724","article-title":"The enzymes and control of eukaryotic mRNA turnover.","volume":"11","author":"Parker","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.cell.2011.09.056","article-title":"Neuralized1 activates CPEB3: a function for nonproteolytic ubiquitin in synaptic plasticity and memory storage.","volume":"147","author":"Pavlopoulos","year":"2011","journal-title":"Cell"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101388","article-title":"Targeting the cytoplasmic polyadenylation element binding protein CPEB4 protects against diet-induced obesity and microbiome dysbiosis.","author":"Pell","year":"2021","journal-title":"Mol. Metab."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e92998","DOI":"10.1371\/journal.pone.0092998","article-title":"HBx down-regulated Gld2 plays a critical role in HBV-related dysregulation of miR-122.","volume":"9","author":"Peng","year":"2014","journal-title":"PLoS One"},{"key":"B66","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies.","volume":"69","author":"Pimpin","year":"2018","journal-title":"J. Hepatol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.3389\/fimmu.2019.02882","article-title":"Interplay between macrophages and angiogenesis: a double-edged sword in liver disease.","volume":"10","author":"Ramirez-Pedraza","year":"2019","journal-title":"Front. Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.tibs.2007.04.004","article-title":"CPEB: a life in translation.","volume":"32","author":"Richter","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1182\/blood-2014-04-526301","article-title":"Marrow failure: a window into ribosome biology.","volume":"124","author":"Ruggero","year":"2014","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature10098","article-title":"Global quantification of mammalian gene expression control.","volume":"473","author":"Schwanh\u00e4usser","year":"2011","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13000-014-0164-1","article-title":"MicroRNA-107 promotes proliferation of gastric cancer cells by targeting cyclin dependent kinase 8.","volume":"9","author":"Song","year":"2014","journal-title":"Diagn. Pathol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.celrep.2015.04.060","article-title":"The CPEB3 protein is a functional prion that interacts with the actin cytoskeleton.","volume":"11","author":"Stephan","year":"2015","journal-title":"Cell Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/ki.2009.62","article-title":"Hypoxia-inducible factor-1\u03b1 induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition.","volume":"75","author":"Sun","year":"2009","journal-title":"Kidney Int."},{"key":"B74","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","article-title":"IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.","volume":"26","author":"Taniguchi","year":"2014","journal-title":"Semin. Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"6977","DOI":"10.18632\/oncotarget.3166","article-title":"Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer.","volume":"6","author":"Tao","year":"2015","journal-title":"Oncotarget"},{"key":"B76","doi-asserted-by":"publisher","first-page":"9602","DOI":"10.1073\/pnas.1133424100","article-title":"Two previously undescribed members of the mouse CPEB family of genes and their inducible expression in the principal cell layers of the hippocampus.","volume":"100","author":"Theis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e0155025","DOI":"10.1371\/journal.pone.0155025","article-title":"Biphasic and stage-associated expression of CPEB4 in hepatocellular carcinoma.","volume":"11","author":"Tsai","year":"2016","journal-title":"PLoS One"},{"key":"B78","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/hipo.22399","article-title":"Characterization of cytoplasmic polyadenylation element binding 2 protein expression and its RNA binding activity: expression and RNA Binding of CPEB2.","volume":"25","author":"Turimella","year":"2015","journal-title":"Hippocampus"},{"key":"B79","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.molcel.2012.05.016","article-title":"Bidirectional control of mRNA translation and synaptic plasticity by the cytoplasmic polyadenylation complex.","volume":"47","author":"Udagawa","year":"2012","journal-title":"Mol. Cell."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2112.e6","DOI":"10.1053\/j.gastro.2009.08.068","article-title":"Role of placental growth factor in mesenteric neoangiogenesis in a mouse model of portal hypertension.","volume":"137","author":"Van Steenkiste","year":"2009","journal-title":"Gastroenterology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4137\/bbi.s5087","article-title":"Comparative in silico analyses of Cpeb1\u20134 with functional predictions.","volume":"4","author":"Wang","year":"2010","journal-title":"Bioinform. Biol. Insights"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD.","volume":"40","author":"Yamamura","year":"2020","journal-title":"Liver Int."},{"key":"B83","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","article-title":"Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.","volume":"117","author":"Yang","year":"2004","journal-title":"Cell"},{"key":"B84","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jhep.2017.10.006","article-title":"Should we undertake surveillance for HCC in patients with NAFLD?","volume":"68","author":"Younes","year":"2018","journal-title":"J. Hepatol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis.","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41419-020-02984-y","article-title":"CPEB3-mediated MTDH mRNA translational suppression restrains hepatocellular carcinoma progression.","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-981-10-8684-7_5","article-title":"NAFLD related-HCC: the relationship with metabolic disorders","author":"Zhang","year":"2018","journal-title":"Obesity, Fatty Liver and Liver Cancer [Internet]"},{"key":"B89","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbrc.2015.09.008","article-title":"MicroRNA-203-mediated posttranscriptional deregulation of CPEB4 contributes to colorectal cancer progression.","volume":"466","author":"Zhong","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e111860","DOI":"10.1371\/journal.pone.0111860","article-title":"miR-107 activates ATR\/Chk1 pathway and suppress cervical cancer invasion by targeting MCL1.","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"key":"B91","doi-asserted-by":"publisher","first-page":"266","DOI":"10.18632\/oncotarget.5689","article-title":"MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3\/EGFR axis in human hepatocellular carcinoma.","volume":"7","author":"Zou","year":"2016","journal-title":"Oncotarget"}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.795298\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T13:50:35Z","timestamp":1638366635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.795298\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":91,"alternative-id":["10.3389\/fphys.2021.795298"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2021.795298","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,29]]},"article-number":"795298"}}